Metabolomic biomarkers enhance 10-year mortality risk calibration and clinical utility in older heart failure patients: A UK Biobank study
{{output}}
Background and aims: While current heart failure models focus on short-term outcomes, long-term risk prediction is essential for an aging population. Given that heart failure is often the terminal manifestation of systemic metabo... ...
